InnoPharma Overview

  • Founded
  • 2005
  • Status
  • Acquired/​Merged
  • Employees
  • 87
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $360M
Latest Deal Amount

InnoPharma General Information


Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophthalmic dosage forms. The company has a broad portfolio of products under development, with formulations including, suspension, lyophilized, emulsions, liposomes, micelles and lipid complexes.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Parent Company
Primary Office
  • 10 Knightsbridge Road
  • Piscataway Township, NJ 08854
  • United States
+1 (732) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InnoPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Sep-2014 $360M 0000 00000 Completed Product Development
3. Debt - General 13-Nov-2013 0000 0000 Completed Product Development
2. Debt - General 07-Jun-2012 $8M $23M Completed Product Development
1. Early Stage VC (Series A) 01-Dec-2011 $15M $15M 000.00 Completed Product Development
To view InnoPharma’s complete valuation and funding history, request access »

InnoPharma Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00 00 00 00 0.000
To view InnoPharma’s complete cap table history, request access »

InnoPharma Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophth
Piscataway Township, NJ
87 As of 2014
0000 0000-00-00
000000&0 0000


u fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia d
Morristown, NJ
0000 As of 0000
000000000 00000

00000 00

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
Franklin Township, NJ
000 As of 0000
0000 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InnoPharma Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alvogen Group Private Equity-Backed Morristown, NJ 0000 00000 000000000 00000
00000 000000000000 Corporate Backed or Acquired Franklin Township, NJ 000 000000&0
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 -
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
00000 Failed Transaction (M&A) Hafnarfjordur, Iceland 000 000000000000
You’re viewing 5 of 19 competitors. Get the full list »

InnoPharma Executive Team (5)

Name Title Board Seat Contact Info
John Deighan Chief Financial Officer
Navneet Puri Ph.D Chief Executive Officer, Board Member, Co-Founder & President
Sriram Ramanathan Chief Operating Officer & Co-Founder
To view InnoPharma’s complete executive team members history, request access »

InnoPharma Board Members (4)

Name Representing Role Since
Peter Werth Self Board Member 000 0000
Raman Kapur Self Board Member 000 0000
To view InnoPharma’s complete board members history, request access »

InnoPharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnoPharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Athyrium Capital Management Asset Manager Minority 000 0000 000000 0
Thomas McNerney & Partners Venture Capital Minority 000 0000 000000 0
To view InnoPharma’s complete investors history, request access »